Challenges of Understanding and Diagnosing Lipedema with Michael Jeltsch, PhD
Dr. Michael Jeltsch tells us that researchers still don’t understand the molecular underpinnings of lipedema and lymphedema. He discusses why finding a genetics component for lipedema is an important step that would give scientists an opportunity to study the disease more extensively. Dr. Jeltsch also explains that diagnoses often aren’t black and white, and that a patient’s quality of life partly determines where they fall in the spectrum of disease. Dr. Michael Jeltsch is an Adjunct Professor and Academy Research Fellow at the University of Helsinki and Director of the Jeltsch Lab Translational Cancer Biology Research Program at the Institute of Biomedicine, Biomedicum Helsinki in Finland. Dr. Jeltsch researches the lymphatic system, lymphangiogenesis, and drug targets for cancer.
Difficulty creates the opportunity for self-reflection and compassion.